부산대학교 도서관

BACKGROUND: Neonatal screening for haemoglobin (Hb) disorders is a standard of care in several developed countries with the main objective to detect Hb S. Such practice has not been established in Thailand where [alpha]-thalassaemia and haemoglobin E (Hb E) are highly prevalent. Early identification of thalassaemias could be helpful and strengthen the programme for prevention and control for severe thalassaemias. METHODS: Data from isoelectric focusing (IEF) and Isoscan(R) for detecting types and amount (%) of each haemoglobin in 350 newborn's dried blood spots were analysed and compared with the comprehensive genotype analysis by DNA studies as a gold standard. RESULTS: Based on genetic profiles, there were 10 different categories: (1) normal (n = 227), (2) [alpha](+)-thalassaemia trait (n = 14), (3) [alpha](0)-thalassaemia trait (n = 13), (4) [beta](0)-thalassaemia trait (n = 7), (5) Hb E trait (n = 72), (6) Hb E trait with [alpha](0)-thalassaemia or homozygous [alpha](+)-thalassaemia (n = 5), (7) Hb E trait with [alpha](+)-thalassaemia trait (n = 5), (8) homozygous Hb E (n = 3), (9) homozygous Hb E with [alpha](0)-thalassaemia trait (n = 1) and (10) Hb H disease (n = 3). The presence of Hb Bart's and Hb E were used to identify cases with [alpha]-thalassaemia and Hb E, respectively. We set 0.25% of Hb Bart's and 1.5% of Hb E as a cut-off level to detect [alpha](+)-thalassaemia trait (sensitivity 92.86% and specificity 74.0%) and Hb E trait with 100% of both sensitivity and specificity for IEF diagnosis. CONCLUSION: Although molecular diagnosis seems to be better for definitive diagnosis of thalassaemia syndromes at birth, however, using our reference range described herein, IEF can be applied in a resource-limiting setting with acceptable reliability. [ABSTRACT FROM AUTHOR]